Jail MentalHealth JPSReport 02-03-2020
Jail MentalHealth JPSReport 02-03-2020
Jail MentalHealth JPSReport 02-03-2020
Topline Findings
In this brief we use data from the Board of State and Community Corrections (BSCC) to estimate the
relative prevalence of mental illness among jail-incarcerated individuals in California over the past ten
years. We reviewed data from counties that completed the BSCC Jail Profile Survey (JPS) between 2009
and 2019. On average, we used data from 50 counties each year for our analytical sample.
Based on our sample, the share of the California statewide jail population either with an active mental
health case or a prescription for a psychotropic medication increased significantly between 2009 and
2019 (see Figure 1 on the next page):
• Active Mental Health Cases. On the last day of any given month in 2009 there were roughly
80,000 people in jail custody throughout California and 15,500 people with an active mental
health case. On the last day of any month in 2019 there were approximately 72,000 people in
jail custody and 22,000 people with an open mental health case. This represents a 42 percent
increase in the number of active mental health cases. In addition, the proportion of
incarcerated people in California jails with an active mental health case rose by approximately
63 percent, rising from 19 percent in 2009 to 31 percent in 2019.
• Psychotropic Medication Prescriptions. In 2009, on the last day of any month, there were
roughly 80,000 people in jail custody across the state and about 10,500 individuals receiving
psychotropic medications. However, in 2019, on the last day of any given month, there were
approximately 72,000 people in jail custody and roughly 19,000 individuals receiving these
psychotropic medications. This represents an 80 percent increase in the total number of
inmates receiving these medications. Moreover, the proportion of jail-incarcerated people
throughout California with a psychotropic medication prescription roughly doubled from 13
percent in 2009 to 26 percent in 2019.
Although these JPS data pertaining to mental illness in jail are useful for estimating the prevalence of
mental illness among the jail incarcerated population in California, these data are incomplete at times.
In our report we provide specific, actionable recommendations to improve the overall data quality.
Page 2
30
Percent (%) of California Jail Population
25
Psychotropic Medication
Prescriptions
20
15
10
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Background
Data on mental illness among incarcerated populations is difficult to obtain. However, the available
data, which mostly comes from surveys, suggests that mental illness in jail or prison is prevalent and
that individuals with a mental illness are overrepresented in jail or prison. About 1 in 4 jail inmates self-
reported experiences that met the threshold for serious psychological distress (SPD) in the 30 days
prior to incarceration, according to the Bureau of Justice Statistics’ 2011-12 National Inmate Survey.1 In
comparison, data from the National Survey on Drug Use and Health2 found that only about 1 in 19
persons in the standardized U.S. general population met the threshold for SPD. In this study we rely
upon administrative data from the state of California to estimate the prevalence of mental illness
among the jail population. There are justifiable concerns about the prevalence of mental illness in jails
and prisons.
• Individuals experiencing mental illness are likely to remain incarcerated longer than their
peers. On average, individuals with mental illnesses receive sentences that are 12 percent
longer than individuals convicted of the same crimes but without mental health diagnoses.3
• Incarcerated people experiencing a mental illness are also more likely to be disciplined and
isolated in segregated housing (i.e., solitary confinement). Once in solitary confinement the
harsh conditions of the segregation worsen the symptoms of mental illness. Moreover, not only
are the mentally ill more likely to be placed in solitary confinement, they often find it
exceedingly difficult to meet the requirements for release.
• People with a mental illness diagnosis are more likely to commit suicide and/or be victimized.
Suicide is the leading cause of death in correctional facilities, and as many as half of all inmate
suicides are committed by the estimated 15 to 25 percent of inmates with serious mental
illness. Untreated mental illness can also contribute to violent victimization in custody.
Individuals with serious mental illness in jail were five times more likely to report that they
were sexually victimized by another inmate than individuals with no mental illness.4
• It is expensive to incarcerate individuals with mental illnesses since jails in the United States
are improperly equipped for treatment. Correctional health care professionals are constantly
constrained by limited or improper resources and large caseloads. Community mental health
treatment is less costly and more effective than incarceration.5
1
BJS National Inmate Survey (NIS).
2
SAMSHA National Survey on Drug Use and Health (NSDUH).
3
Stanford Justice Advocacy Project. “The Prevalence and Severity of Mental Illness Among California Prisoners.” 2017.
4
Bureau of Justice Statistics. “Sexual Victimization in Prisons and Jails Reported by Inmates, 2011-2012.” 2013.
5
The annual cost of incarcerating an average jail inmate in California is estimated at $30,000, not including mental health
care costs, while the cost of treating a person with mental illness in the community is approximately $20,000, according to
the Judicial Council of California report entitled “Task Force for Criminal Justice Collaboration on Mental Health Issues: Final
Report” from 2011.
Methodology
Since 2002, the BSCC has conducted the Jail Profile Survey (JPS) to collect data regarding local agency
jails and jail systems.6,7 County-wide data are gathered monthly and counties submit their data on a
voluntary basis. In the monthly survey, counties are asked to report average daily population (ADP) for
the month. ADP is the monthly average, excluding people on holding status. Importantly, the survey
also requests that counties report the “number of inmates on the last day of the month who are
receiving psychotropic medications for identified mental health disorders.” The survey also asks
counties to report the “number of open mental health cases on the last day of the month.” Active (i.e.,
open) mental health cases are inmates identified as having a psychological disorder and who are
actively in need of and receiving mental health services. The number of psychotropic medication
prescriptions and the number of inmates receiving mental health services are counted on the last day
of each month, and so they represent point-in-time counts.
We developed analytical samples of all California jails independently by both survey question and year.
Furthermore, we generated two samples per year – one for our analysis of active mental health
caseloads and another for our analysis of psychotropic medications. Jurisdictions that responded to the
JPS questions about mental illness for at least two reporting periods during a given year are included in
that respective analytical sample. Appendix A details which counties are included. We use data from
the vast majority of jails across the state and the sample is diverse.8 The JPS data is incomplete at times
and there are some notable issues that should be addressed with the survey series to improve its
quality and usefulness. In this report we took a conservative, descriptive approach to our analysis that
uses the maximum amount of the available non-missing data and summarizes it. In the final section of
this report we offer recommendations to improve the data. We believe that the mental health data
gathered from the JPS can be significantly enhanced with greater BSCC oversight.
In this report we use the results from this JPS series to better estimate the prevalence of mental illness
in jail. We focus our analysis on the data gathered from the questions pertaining to (1) the month-end
number of psychotropic medication prescriptions, (2) the month-end number of active mental health
cases, and (3) the month-end jail population (i.e., ADP). From these questions we calculated both
annual and statewide estimates for the following measures:9
• Raw number (i.e., count) of individuals with either an open mental health case or a
psychotropic medication prescription;
• Percent of the jail population with either an open mental health case or a psychotropic
medication prescription; and
• Total Change (i.e., long-run change) in the percent of the jail population with either an open
mental health case or a psychotropic medication prescription.
6
The BSCC provides a “workbook” with instructions for reporting entities. This form is publicly available.
7
The BSCC administers the JPS using an Excel fillable form. This form is also publicly available.
8
The sample is diverse in terms of geographic coverage since counties from every region of California are consistently
included. Moreover, the sample is diverse with respect to the underlying demographic makeup of the reporting county jails.
Statewide Findings
A growing number of jail-incarcerated individuals are experiencing mental illness in California.
Moreover, the share of the statewide jail population experiencing some form of mental illness, as
reported to the BSCC, has increased significantly since 2009.
The percent of the statewide annual ADP with an open mental health case increased by 11
percentage points or about 62 percent. In 2009, approximately 19 percent of the annual ADP
had an active mental health case across the jurisdictions that reported. During 2019 though,
approximately 30 percent of the annual ADP had an open case in these same jurisdictions.
Psychotropic Medication
The raw number of incarcerated individuals receiving psychotropic medications increased by
roughly 81 percent between 2009 and 2019. During 2009, there was an average of about
10,500 individuals on psychotropic medications on the last day of any given month across all
the jurisdictions in this sample. During 2019,10 there was an average of 19,000 individuals
receiving psychotropic medications on the last day of any given month across the same
reporting jurisdictions.
10
January 2019 to June 2019.
Figure 2a. Estimated Count and Prevalence of Active Mental Health Cases Statewide, 2009 - 2019
25,000 35
Average number of open mental health cases last day of month
Percent of jail population with open mental health case
30
Average number of open mental cases last day of month
25
15,000
20
15
10,000
10
5,000
0 0
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Figure 2b. Estimated Count and Prevalence of Psychotropic Medications Statewide, 2009 - 2019
20,000 30
Average number of people receiving psychotropic meds last day of month
Percent of jail population receiving psychotropic meds
Average number of people receiving psychotropic meds last day of month
25
20
12,000
15
8,000
10
4,000
5
0 0
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Psychotropic Medications
In 2019, the share of the jail ADP receiving psychotropic medications varied widely between
counties. About 23 percent of the jail population receives at least one psychotropic medication
in the median California county.12 However, in Modoc and Siskiyou County, roughly 50 to 56
percent of the annual ADP receives psychotropic medications. Conversely, in Glenn and Madera
County only about 8 or 9 percent of the ADP receives psychotropic medications. In Los Angeles
approximately 35 percent of the jail population receives psychotropic medications. Roughly 25
percent of San Diego and San Francisco’s jail population receives some medications.
11
Orange county was the “median” (50th percentile) jurisdiction in terms of the prevalence of open mental health cases
amongst the jail population in 2019.
12
Fresno county was the “median” (50th percentile) jurisdiction with respect to the prevalence of psychotropic medications
amongst their jail population in 2019.
Figure 3a. Percent of Jail Population with Active Mental Health Case in 2019
State Median State Median
Amador Nevada
Butte Orange
Calaveras Placer
Colusa Plumas
Contra Costa Riverside
Del Norte San Benito
El Dorado San Bernardino
Fresno San Diego
Glenn
San Francisco
Humboldt
San Luis Obispo
Imperial
San Mateo
Inyo
Santa Clara
Kern
Santa Cruz
Kings
Shasta
Lake
Siskiyou
Lassen
Solano
Los Angeles
Madera Sonoma
Marin Stanislaus
Mariposa Tehama
Mendocino Trinity
Merced Tulare
Modoc Tuolumne
Mono Yolo
Napa Yuba
0 10 20 30 40 50 60 70 80 90 100 0 10 20 30 40 50 60 70 80 90 100
Alameda Nevada
Amador Orange
Butte Placer
Calaveras Plumas
Colusa
Riverside
Contra Costa
San Benito
Del Norte
San Bernardino
El Dorado
San Diego
Fresno
Glenn San Francisco
Humboldt San Luis Obispo
Imperial San Mateo
Inyo Santa Barbara
Kern Santa Clara
Kings Santa Cruz
Lake Shasta
Lassen Siskiyou
Los Angeles Solano
Madera
Sonoma
Marin
Stanislaus
Mariposa
Tehama
Mendocino
Trinity
Merced
Modoc Tulare
Mono Tuolumne
Monterey Yolo
Napa Yuba
0 10 20 30 40 50 60 0 10 20 30 40 50 60
Psychotropic Medications
Similarly, counties have experienced markedly different degrees of total change in the
estimated share of their jail population receiving psychotropic medications since 2009. In
Santa Clara County, the share of their jail population receiving psychotropic medications
increased by about 30 percentage points from 2009 to 2019. In Los Angeles County, this rate
increased by 22 percentage points over this same period. However, in Butte County this rate
fell by a total of 2 percentage points. The average county saw the percent of their jail
population receiving psychotropic medications climb approximately 11 percentage points
between 2009 and 2019.
13
See Appendix C for a discussion about the annualized year-over-year change in both the percent of county jail
populations with either an active mental health case or a psychotropic medication.
Figure 4a. Total Change in the Percent of the Jail Population with an Active Mental Health Case
by County Between 2009 and 2019
Butte
Calaveras
El Dorado
Fresno
Humboldt
Imperial
Kern
Kings
Lake
Los Angeles
Madera
Mendocino
Merced
Napa
Nevada
Orange
Placer
Riverside
San Benito
San Bernardino
San Diego
San Francisco
San Luis Obispo
San Mateo
Santa Clara
Santa Cruz
Shasta
Solano
Sonoma
Stanislaus
Tehama 2019
Tuolumne
Yolo 2009
Yuba
0 20 40 60 80 100
Percent ADP with Open Mental Health Case in 2009 vs 2019
Note: The 36 largest counties, by resident population, with non-negative JPS responses in 2009 and 2019 are shown.
Figure 4b. Total Change in the Percent of the Jail Population Receiving Psychotropic Medications
by County Between 2009 and 2019
Alameda
Butte
El Dorado
Fresno
Humboldt
Imperial
Kern
Kings
Lake
Los Angeles
Madera
Mendocino
Merced
Monterey
Napa
Nevada
Orange
Placer
Riverside
San Benito
San Bernardino
San Diego
San Francisco
San Luis Obispo
San Mateo
Santa Barbara
Santa Clara
Santa Cruz
Shasta
Solano
Sonoma
Stanislaus
Tehama 2019
Tuolumne
Yolo 2009
Yuba
0 10 20 30 40 50
Percent ADP Prescribed Psychotropic Meds in 2009 vs 2019
Note: The 36 largest counties, by resident population, with non-negative JPS responses in 2009 and 2019 are shown.
Discussion
According to the BJS’s national studies on this population, about a third (roughly 35 percent) of jail
inmates who met the threshold for serious psychological distress (SPD) had received mental health
treatment since admission to their current facility.14 In comparison, 38 percent of jail inmates who had
ever been told that they had a mental disorder said they were currently receiving treatment for a
mental health problem. 15 An estimated 30 percent of jail inmates said they were currently taking
prescription medication.16 In our study we rely upon the number of psychotropic medication
prescriptions and open psychiatry cases to estimate the prevalence of mental illness. However, our
estimates are likely biased downwards (i.e., our estimates are likely conservative), since national
studies have shown that a significant share of the jail-incarcerated people battling mental illness do not
receive treatment.
There are a few different explanations for why the share of the statewide jail population with either a
prescription for psychotropic medications or an active mental health cases has increased since 2009:
• This finding could reflect a trend toward the increased incarceration of seriously mentally ill
individuals. Local factors, such as increased homelessness or defendants increasingly found
Incompetent to Stand Trial (IST), could potentially contribute to this trend. Alternatively, the
consequences of state policy changes under Public Safety Realignment that have redirected
inmates with lower level offenses to jail who previously had been sentenced to prison could be
driving this trend. One policy objective of Realignment was to make it easier to connect inmates
serving short sentences with community resources, such as behavioral health services and
treatment, that would improve recidivism.
• The increase we observe in the rate of the incarcerated jail population with either an open case
or an active psychotropic medication prescription might not be due to increased numbers of
incarcerations of mentally ill individuals, but rather to better identification, diagnosis, and
treatment of seriously mentally ill individuals in jails. Further research should focus on
identifying the ways in which jails have changed their practices during this period.
Measuring the number of jail inmates receiving psychotropic medications or with an open case file
could serve as a possible proxy for the number of individuals with mental illness in jail. However,
the reliability of these figures depends on the consistency of mental health assessment, diagnostic,
and treatment practices in all jails. A standard screening and assessment process could allow for a
more precise accounting of the mentally ill population in California and allow for more efficient
allocation of funds/resources.17 However, in the short term, the BSCC data provides a useful
baseline to help understand local incarceration trends related to individuals with mental illness and
can help inform policies that attempt to address this issue.
14
BJS Indicators of Mental Health Problems Reported by Prisoners and Jail Inmates, 2011-2012.
15
Ibid.
16
Ibid.
17
The Council on Criminal Justice and Behavioral Health (CCJBH), formerly known as the Council of Mentally Ill Offenders
(COMIO), and others have recommended the adoption of standardized screening and assessment tools at booking.
18
California Penal Code Section 3500(c) [Link]
19
These drugs include, but are not limited to, antipsychotic, antianxiety, sedative, antidepressant, and stimulant drugs.
Psychotropic drugs also include mind-altering and behavior altering drugs that, in specified dosages, are used to alleviate
certain physical disorders, and drugs that may be ordinarily used to alleviate certain physical disorders.
The following two tables demonstrate which counties are included in our study and during which
years. A black check mark (✓) indicates that a given county reported for that period and is included in
the statewide sample. Conversely a red highlighted cross mark (✗) indicates that a given county is
excluded from the statewide sample because they did not sufficiently report during that period.
4$%5(8 − 4$%5(89:
7++5$% '()*(+# ,ℎ$+.( =
4$%5(89:
4$%5(8 = value in any given year (year k)
4$%5(89: = value in previous year (year k-1)
Average annual percent change is a measure of the average “year-over-year” change. This is a linear
measure that is the arithmetic mean of all the observed annual percent changes over the time period.
Annualized percent change (i.e., compound annual percent change) is a “smooth” measure of the
average observed annual percent change. This metric is the geometric mean of all the observed annual
percent changes. The annualized percent change is useful for comparing change between different
counties. The annualized percent change offers a single measure of change for the entire period which,
had it applied at all times throughout that period, would have led to the same total change as was
observed. Over long periods of time, the compound annual percent change is a generally acceptable
and preferred metric for average change. The most important limitation of this metric is that because it
calculates a smoothed rate of change over a period, it ignores volatility and implies that the change
during that time was steady.
:
2019 4$%5( ::
7++5$%AB(C '()*(+# ,ℎ$+.( = −1
2009 4$%5(
The majority of counties in California experienced increases in the prevalence of mental illness in their
jails year-over-year. However, the annualized year-over-year change in the relative prevalence of
mental illness among jail-incarcerated people was also significantly different across counties.
Psychotropic Medications
Between 2009 and 2019, counties also experienced markedly different degrees of annualized
year-over-year change in the share of their jail population receiving psychotropic medications.
The median annualized change in rate of psychotropic medication prevalence in California jails
was roughly 6 percent, but across the state, annualized rates of changes ranged from 9 percent
increases to 23 percent decreases. In Fresno and Kern County, the number of people receiving
psychotropic medications increased by about 10 to 13 percent per year, on average. Los
Angeles County experienced an average change of about 9 percent year-over-year. Some
counties, such as Humboldt and Napa experienced small change of less than 1 percent per year
on average over this time period.